| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.07. | CapsoVision beruft Gastroenterologen David Shields in den Verwaltungsrat | 4 | Investing.com Deutsch | ||
| 02.07. | CapsoVision appoints gastroenterologist David Shields to board | 1 | Investing.com | ||
| 02.07. | CapsoVision, Inc - 8-K, Current Report | 1 | SEC Filings | ||
| 02.07. | CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors | 101 | GlobeNewswire (Europe) | SARATOGA, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (Nasdaq: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions... ► Artikel lesen | |
| CAPSOVISION Aktie jetzt für 0€ handeln | |||||
| 12.06. | CapsoVision: Aktionäre bestätigen Direktoren und Wirtschaftsprüfer auf Jahreshauptversammlung | 2 | Investing.com Deutsch | ||
| 12.06. | CapsoVision, Inc - 8-K, Current Report | 2 | SEC Filings | ||
| 15.05. | Benchmark reiterates Speculative Buy on CapsoVision stock at $10 | 1 | Investing.com | ||
| 15.05. | CapsoVision expects AI-assisted reading clearance around midyear, with CapsoCam Colon Gen 2 imaging and AI module targeted for Q3 2026 | 6 | Seeking Alpha | ||
| 14.05. | Transcript: CapsoVision Q1 2026 Earnings Conference Call | 1 | Benzinga.com | ||
| 14.05. | CapsoVision, Inc. GAAP EPS of -$0.15 misses by $0.02, revenue of $2.8M misses by $0.18M | 1 | Seeking Alpha | ||
| 14.05. | CapsoVision, Inc - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 14.05. | CapsoVision, Inc - 8-K, Current Report | 1 | SEC Filings | ||
| 30.04. | CapsoVision to Release First Quarter 2026 Financial Results on May 14, 2026 | 1 | GlobeNewswire (USA) | ||
| 17.04. | CapsoVision, Inc - S-1, General form for registration of securities | - | SEC Filings | ||
| 27.03. | CapsoVision targets 510(k) submission for Gen 2 Colon capsule and AI module in Q3 2026 as commercial adoption accelerates | 1 | Seeking Alpha | ||
| 26.03. | CapsoVision, Inc - 10-K, Annual Report | 1 | SEC Filings | ||
| 26.03. | CapsoVision, Inc. reports Q4 results | 4 | Seeking Alpha | ||
| 20.03. | CapsoVision Climbs on Hefty Private Placement | 2 | Baystreet.ca | ||
| 20.03. | CapsoVision closes $14 million private placement financing | 1 | Investing.com | ||
| 20.03. | CapsoVision Announces $14 Million Private Placement Financing | 1 | GlobeNewswire (USA) |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 71,44 | +0,01 % | Raymond James initiates BrightSpring Health stock with outperform rating | ||
| LIFESTANCE HEALTH GROUP | 10,705 | 0,00 % | LifeStance Health Group, Inc. - 8-K, Current Report | ||
| ALIGNMENT HEALTHCARE | 19,830 | 0,00 % | Kaplan Fox & Kilsheimer LLP: Kaplan Fox Alerts Investors of Alignment Healthcare, Inc. (ALHC) to an Investigation of Potential Securities Law Violations | New York, New York--(Newsfile Corp. - July 10, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or... ► Artikel lesen | |
| BILLIONTOONE | 127,06 | +0,23 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 20,900 | +0,05 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| HEARTFLOW | 26,720 | 0,00 % | Heartflow, Inc.: New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease Management | ||
| PRIVIA HEALTH GROUP | 27,490 | 0,00 % | Privia Health Group, Inc. - 8-K, Current Report | ||
| CLEARPOINT NEURO | 17,500 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint | Announcement is made after successful proof-of-concept trial in a preclinical model of intravenous delivery of large molecule tracers across the blood-brain barrier guided by prototype systems, including... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 9,710 | +0,10 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Completes Acquisition of Family First Homecare and Updates Full Year 2026 Guidance | ATLANTA, June 02, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient... ► Artikel lesen | |
| BETA BIONICS | 17,030 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | IRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| KESTRA MEDICAL TECHNOLOGIES | 26,010 | +0,08 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial Results | KIRKLAND, Wash., March 17, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results... ► Artikel lesen | |
| MIMEDX | 4,110 | 0,00 % | MiMedx Group, Inc: MIMEDX Announces Launch of G4Derm Plus | Flowable Biomimetic Matrix Adds Self-Assembling Peptide Technology to Company's Portfolio G4Derm Plus Added to Premier and Vizient GPO Agreements MARIETTA, Ga., May 08, 2026 (GLOBE NEWSWIRE) -- MiMedx... ► Artikel lesen | |
| ALPHA TAU MEDICAL | 12,690 | -0,16 % | Alpha Tau Medical Ltd.: Alpha Tau Successfully Treats First Recurrent Glioblastoma Patient Outside of the United States with Alpha DaRT at Hadassah University Medical Center in Israel | - First glioblastoma patient ever treated with Alpha DaRT® outside of the United States, and the first in Israel - performed at Hadassah University Medical Center in Jerusalem, one of the world's... ► Artikel lesen | |
| TALKSPACE | 5,225 | -0,10 % | Talkspace Stockholders Vote to Approve Acquisition by UHS | NEW YORK, May 29, 2026 (GLOBE NEWSWIRE) -- Talkspace, Inc. ("Talkspace") (Nasdaq: TALK) today announced that at the special meeting of Talkspace stockholders held on May 29, 2026, the Talkspace stockholders... ► Artikel lesen | |
| ADAPTHEALTH | 10,210 | -0,10 % | AdaptHealth Flags Material Breach After Threat Actor Accessed Patient Management Systems |